Knowledge Center

Patent / Jun 29, 2017

Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition

Authors:
  • Mohammad Salman
  • Arturo Angel
  • Vijaya Swaminathan
  • George Magrath
Source:
US 20170182071 A1 20170629

The invention relates to a topical suspension formulation that includes a tetracycline, a liq. medium and a polymeric gelling agent. The tetracycline may be in the form of its pharmaceutically acceptable salts, hydrates, or polymorphs and is in a suspended form within the formulation. The liq. medium is selected such that it does not dissolve or substantially minimally dissolves the tetracycline. The gelling agent is a polymeric hydrocarbon gelling agent. Preferably, the tetracycline has a particle size of less than or equal to about 20 μ.

Also in the Knowledge Center

Related Content

High value applications

ËÄÉ«AV provides off-patent APIs that can be used with confidence where the choice of active ingredient is critical.

Page
Read more

ËÄÉ«AV Expands Global Spray Drying Capacity with Significant Investment in the USA and Ireland

Press Release / Nov 26, 2024
Article
View

Drug Product Development

Leveraging our expertise particle engineering, ËÄÉ«AV can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more